Presentation is loading. Please wait.

Presentation is loading. Please wait.

Downstream coronary effects of drug-eluting stents

Published byDonald Baker Modified over 6 years ago

Similar presentations

Presentation on theme: "Downstream coronary effects of drug-eluting stents"— Presentation transcript:

1 Downstream coronary effects of drug-eluting stents
Richard A. Krasuski, MD, George M. Cater, MSE, Ganesh P. Devendra, MD, Kathy Wolski, MPH, Mehdi H. Shishehbor, DO, MPH, Steven E. Nissen, MD, Carlos Oberti, MD, Stephen G. Ellis, MD  American Heart Journal  Volume 162, Issue 4, Pages e1 (October 2011) DOI: /j.ahj Copyright © 2011 Mosby, Inc. Terms and Conditions

2 Figure 1 Cohort identification and selection.
American Heart Journal  , e1DOI: ( /j.ahj ) Copyright © 2011 Mosby, Inc. Terms and Conditions

3 Figure 2 Kaplan-Meier analysis of new lesion development in control and target vessels for both the entire (A) and the propensity-matched (B) cohorts. American Heart Journal  , e1DOI: ( /j.ahj ) Copyright © 2011 Mosby, Inc. Terms and Conditions

4 Figure 3 Kaplan-Meier analysis of new interventions in control and target vessels for both the entire (A) and the propensity-matched (B) cohorts. American Heart Journal  , e1DOI: ( /j.ahj ) Copyright © 2011 Mosby, Inc. Terms and Conditions

5 Supplementary Figure 1 Downstream Vessel Determination.
American Heart Journal  , e1DOI: ( /j.ahj ) Copyright © 2011 Mosby, Inc. Terms and Conditions

Download ppt "Downstream coronary effects of drug-eluting stents"

Similar presentations

Chronic Lyme Disease: A Survey of Connecticut Primary Care Physicians Michael Johnson, MD, Henry M. Feder, MD The Journal of Pediatrics Volume 157, Issue.

Chronic Lyme Disease: A Survey of Connecticut Primary Care Physicians Michael Johnson, MD, Henry M. Feder, MD The Journal of Pediatrics Volume 157, Issue.
Validity of the LaFarge equation for estimation of oxygen consumption in ventilated children with congenital heart disease younger than 3 years—A revisit.

Validity of the LaFarge equation for estimation of oxygen consumption in ventilated children with congenital heart disease younger than 3 years—A revisit.
Effects of β-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal.

Effects of β-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal.
Atrial fibrillation and quality of life after pacemaker implantation for sick sinus syndrome: Data from the Mode Selection Trial (MOST)  Kirsten E. Fleischmann,

Atrial fibrillation and quality of life after pacemaker implantation for sick sinus syndrome: Data from the Mode Selection Trial (MOST)  Kirsten E. Fleischmann,
Overview of the 2012 Food and Drug Administration Circulatory System Devices Panel of the Medical Devices Advisory Committee meeting on the Edwards SAPIEN.

Overview of the 2012 Food and Drug Administration Circulatory System Devices Panel of the Medical Devices Advisory Committee meeting on the Edwards SAPIEN.
Utility of the Seattle Heart Failure Model in patients with cardiac resynchronization therapy and implantable cardioverter defibrillator referred for.

Utility of the Seattle Heart Failure Model in patients with cardiac resynchronization therapy and implantable cardioverter defibrillator referred for.
Agreement between public register and adjudication committee outcome in a cardiovascular randomized clinical trial  Erik Kjøller, MD, DMSc, Jørgen Hilden,

Agreement between public register and adjudication committee outcome in a cardiovascular randomized clinical trial  Erik Kjøller, MD, DMSc, Jørgen Hilden,
Balloon aortic valvuloplasty in the era of transcatheter aortic valve replacement: Acute and long-term outcomes  Hélène Eltchaninoff, MD, Eric Durand,

Balloon aortic valvuloplasty in the era of transcatheter aortic valve replacement: Acute and long-term outcomes  Hélène Eltchaninoff, MD, Eric Durand,
Rosa Burgers, MD, Alon D. Levin, MD, Carlo Di Lorenzo, MD, Marcel G. W

Rosa Burgers, MD, Alon D. Levin, MD, Carlo Di Lorenzo, MD, Marcel G. W
Ali Ahmed, MD, MPH, Gilbert J. Perry, MD, Jerome L. Fleg, MD, Thomas E

Ali Ahmed, MD, MPH, Gilbert J. Perry, MD, Jerome L. Fleg, MD, Thomas E
The impact of peripheral arterial disease on early outcome after transcatheter aortic valve implantation  Jan-Malte Sinning, MD, Martin Horack, MS, Eberhard.

The impact of peripheral arterial disease on early outcome after transcatheter aortic valve implantation  Jan-Malte Sinning, MD, Martin Horack, MS, Eberhard.
Rationale and design of the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) 3 Trial: A comparison of fractional flow reserve–guided.

Rationale and design of the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) 3 Trial: A comparison of fractional flow reserve–guided.
A critical review of hemodynamic changes and left ventricular remodeling after surgical aortic valve replacement and percutaneous aortic valve replacement 

A critical review of hemodynamic changes and left ventricular remodeling after surgical aortic valve replacement and percutaneous aortic valve replacement 
American Heart Journal

American Heart Journal
The outcome of primary percutaneous coronary intervention for stent thrombosis causing ST-elevation myocardial infarction  Mehmet Ergelen, MD, Sevket.

The outcome of primary percutaneous coronary intervention for stent thrombosis causing ST-elevation myocardial infarction  Mehmet Ergelen, MD, Sevket.
Severe Tuberculosis Sepsis in an Immunocompetent Patient

Severe Tuberculosis Sepsis in an Immunocompetent Patient
The Adherence eValuation After Ischemic Stroke Longitudinal (AVAIL) Registry: Design, rationale, and baseline patient characteristics  Cheryl Bushnell,

The Adherence eValuation After Ischemic Stroke Longitudinal (AVAIL) Registry: Design, rationale, and baseline patient characteristics  Cheryl Bushnell,
Evaluation of a novel anti-ischemic agent in acute coronary syndromes: Design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia.

Evaluation of a novel anti-ischemic agent in acute coronary syndromes: Design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia.
Sex differences in health behavior change after premature acute coronary syndrome  Sylvie S.L. Leung Yinko, RD, MSc, Janane Maheswaran, BSc, Roxanne Pelletier,

Sex differences in health behavior change after premature acute coronary syndrome  Sylvie S.L. Leung Yinko, RD, MSc, Janane Maheswaran, BSc, Roxanne Pelletier,
Previous coronary stents do not increase early and long-term adverse outcomes in patients undergoing off-pump coronary artery bypass grafting: A propensity-matched.

Previous coronary stents do not increase early and long-term adverse outcomes in patients undergoing off-pump coronary artery bypass grafting: A propensity-matched.

Similar presentations

Ads by Google